National Health Investors (NYSE:NHI) Stock Price Expected to Rise, Truist Financial Analyst Says

National Health Investors (NYSE:NHI) had its price objective increased by Truist Financial from $70.00 to $76.00 in a report published on Wednesday,Benzinga reports. The firm currently has a hold rating on the real estate investment trust’s stock.

Separately, Wedbush restated an “outperform” rating and set a $88.00 price objective on shares of National Health Investors in a research report on Monday. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, National Health Investors presently has a consensus rating of “Hold” and a consensus price target of $85.50.

National Health Investors Trading Down 0.6 %

Shares of NHI stock opened at $75.58 on Wednesday. National Health Investors has a 52-week low of $57.80 and a 52-week high of $86.13. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. The firm has a market capitalization of $3.45 billion, a PE ratio of 25.97, a PEG ratio of 4.42 and a beta of 1.08. The stock has a fifty day simple moving average of $70.08 and a two-hundred day simple moving average of $74.68.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.03. The firm had revenue of $85.75 million during the quarter, compared to analyst estimates of $81.13 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. On average, analysts predict that National Health Investors will post 4.41 EPS for the current fiscal year.

National Health Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 2nd. Investors of record on Monday, March 31st will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.76%. The ex-dividend date of this dividend is Monday, March 31st. National Health Investors’s payout ratio is 115.38%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in NHI. Norges Bank bought a new position in shares of National Health Investors in the 4th quarter valued at about $42,322,000. Millennium Management LLC lifted its holdings in shares of National Health Investors by 1,967.0% in the 4th quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust’s stock valued at $33,843,000 after acquiring an additional 464,727 shares during the last quarter. Balyasny Asset Management L.P. bought a new position in shares of National Health Investors in the 4th quarter valued at about $23,917,000. Marshall Wace LLP lifted its holdings in shares of National Health Investors by 161.6% in the 4th quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust’s stock valued at $38,225,000 after acquiring an additional 340,712 shares during the last quarter. Finally, Zimmer Partners LP bought a new position in shares of National Health Investors in the 3rd quarter valued at about $25,218,000. Institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.